Authors: Belzberg, Micah; Alphonse, Martin Prince; Brown, Isabelle; Williams, Kyle A.; Khanna, Raveena; Ho, Byron; Wongvibulsin, Shannon; Pritchard, Thomas; Roh, Youkyung Sophie; Sutaria, Nishadh; Choi, Justin; Jedrych, Jaroslaw; Johnston, Andrew D.; Sarkar, Kakali; Vasavda, Chirag; Meixiong, Jimmy; Dillen, Carly; Bondesgaard, Kent; Paolini, John F.; Chen, Wei; Corcoran, David; Devos, Nicolas; Kwatra, Madan M.; Chien, Anna L.; Archer, Nathan K.; Garza, Luis A.; Dong, Xinzhong; Kang, Sewon; Kwatra, Shawn G.
Issue: J Invest Dermatol . 2021 Mar 23;S0022-202X(21)01016-2.
Prurigo nodularis (PN) is an understudied, chronic inflammatory skin disease that disproportionately affects African Americans and presents with intensely pruritic nodules of unknown etiology. To better characterize the immune dysregulation in PN, PBMCs and skin biopsies were obtained from patients with PN and healthy subjects (majority African American) matched by age, race, and sex. Flow cytometric analysis of functional T-cell response comparing patients with PN with healthy subjects identified increased γδT cells (CD3+CD4-CD8-γδTCR+) and Vδ2+ γδT enrichment. Activated T cells demonstrated uniquely increased IL-22 cytokine expression in patients with PN compared with healthy controls. CD4+ and CD8+ T cells were identified as the source of increased circulating IL-22. Consistent with these findings, RNA sequencing of lesional PN skin compared with nonlesional PN skin and biopsy site‒matched control skin demonstrated robust upregulation of T helper (Th) 22‒related genes and signaling networks implicated in impaired epidermal differentiation. Th22‒related cytokine upregulation remained significant, with stratifications by race and biopsy site. Importantly, the expression of the IL-22 receptors IL22RA1 and IL22RA2 was significantly elevated in lesional PN skin. These results indicate that both systemic and cutaneous immune responses in patients with PN are skewed toward a Th22/IL-22 profile. PN may benefit from immunomodulatory therapies directed at Th22‒mediated inflammation.